Tag Archives: Pharma

Pharma Gets the ProPublica Treatment

Alternative news organization and media allies investigate the industry’s payments to doctors—launching a fresh assault on the ethical status quo. By Walter Armstrong Last week, Big Pharma’s practice of paying doctors to do medical education, promote its products, or both was the focus of a multimedia blitz launched by ProPublica in collaboration with National Public Radio, the [...]
Posted in FDA, Legal, Medical Education, Meetings | Also tagged , , , , | 6 Comments

Social Media and Healthcare Consumers: A Report

In the past decade, social networking has changed the way most of us live our day-to-day lives. So how has it affected pharma’s relationship with consumers, and vice versa? A recent report from ROI Research grants a glimpse into this changing relationship. Social networking is no longer something people (patients, healthcare providers, physicians) are merely talking [...]
Posted in E-Media, Technology, social media | Also tagged , , , | Leave a comment

What Is Behind the Genzyme Job Cuts?

Troubled biotech Genzyme’s (Cambridge, MA) planned elimination of over 1,000 jobs (10% of its 12,800 workforce, according to the Boston Globe) over the next 15 months is not related to the takeover bid from French giant Sanofi Aventis, the company has said.
Posted in Deals, Global, Strategy | Also tagged , , , , , | Leave a comment

Patients Want to Talk. Do You?

Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law. It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Posted in E-Media, Europe, FDA, Global, Guest Blog, Legal | Also tagged , , , , | 2 Comments

Nothing is Rotten in the State of Denmark

Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent. Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , | Leave a comment